Form D · Biotechnology
Biuveris, Inc.
Santa Fe, NM · CIK 0001798795
Offering snapshot reported Jan 14, 2020 · SEC filing
- Reported sold
- $6.08K Offering amount: $6.08K
- Investors reported
- 39 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2020 | Initial | $6,077 | No comparison | 39 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-357999
Source: Form D, filed Jan 14, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Humbert | Director, Executive, Promoter |
| Alexander Koglin | Director, Executive, Promoter |
| Thomas R. Nickoloff | Director, Executive |
| David Seldin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Tatc 822 M, 6401 Richards Ave
Santa Fe, NM, 87508
Santa Fe, NM, 87508